Clinical trialNCT05602363RecruitingPhase 1Interventional

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

SponsorCarna Biosciences, Inc.Enrollment120B-cell MalignancyChronic Lymphocytic LeukemiaFollicular LymphomaMantle Cell LymphomaMarginal Zone LymphomaNon-Hodgkin Lymphoma+2 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Uc Irvine Health
Orange, California, United States
Catherine Coombs, MD
Recruiting
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
Jacqueline Barrientos, MD
Recruiting
Moffitt Cancer Center
Tampa, Florida, United States
Javier Pinilla-Ibarz, MD PhD
Recruiting
Northwestern Memorial Hospital
Chicago, Illinois, United States
Shuo Ma, MD PhD
Recruiting
American Oncology Partners
Fort Wayne, Indiana, United States
Sunil Babu, MD
Recruiting
University of Maryland Medical Center - Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, United States
Seung Tae Lee, MD PhD
Recruiting
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
Andrew J Gillis-Smith, MD
Recruiting
Optum Medical Care Pc
Westbury, New York, United States
Jonathan Goldberg, MD
Recruiting
Duke University
Durham, North Carolina, United States
Danielle Brander, MD
Recruiting
Taylor Cancer Research Center
Maumee, Ohio, United States
John Nemunaitis, MD
Recruiting
Oncology Consultants
Houston, Texas, United States
Julio A Peguero, MD
Recruiting
University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Nitin Jain, MD
Recruiting
the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Nirav Shah, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Docirbrutinib

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Aug 2023
Primary completion: 30 Sept 2027
Completion: 30 Sept 2027
Last update posted: 10 Dec 2025
Registered enrollment: 120
Registry id: NCT05602363

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.